agilon health vs P3 Health Partners
AGL and PIII side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGL and PIII compare
agilon health is the larger company, worth 99 times as much as P3 Health Partners ($1.9B against $19.6M).
P3 Health Partners grew revenue faster over the last twelve months (7.5% versus 2.0% for agilon health).
agilon health keeps more of each dollar of sales as profit, with a net margin of −1.5% compared with −3.3% at P3 Health Partners.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGL | PIII |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $19.6M |
| Share price | $115.66 | $2.70 |
| Change, 1 year | 637% | −64.6% |
| Change, 5 years | −80.5% | −99.5% |
| Beta (5Y) | 1.28 | 1.16 |
| Employees | 856 | 320 |
| StockData Score | ||
| Total score | 4 | 4 |
| Valuation score | 1 | 1 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 1 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× | 0.0× (better) |
| EV/EBITDA | – | 36.9× |
| FCF yield | −0.88% | – |
| Growth | ||
| Revenue growth (TTM) | 2.0% | 7.5% (better) |
| Revenue growth, 5Y average | 37.2% (better) | 24.3% |
| Profitability | ||
| Operating margin | −2.6% (better) | −5.2% |
| Net margin | −1.5% (better) | −3.3% |
| FCF margin | −0.28% | – |
| Return on invested capital | – | −32.7% |
| Financial health | ||
| Net debt / EBITDA | – | 28.58 |
| Interest coverage | −22.4× | – |
| Current ratio | 1.13 (better) | 0.53 |
| Altman Z-score | 2.87 (better) | 0.29 |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 95.8% | 65.0% |
| Held by insiders | 10.1% | 98.0% |
| Insider net buying, 12 months | $300K (better) | −$824K |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.6% | – |
Go deeper
- AGL stock overview
- AGL income statement
- AGL valuation and score
- PIII stock overview
- PIII income statement
- PIII valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.